RETROVIR

This brand name is authorized in Austria, Australia, Canada, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Ireland, Israel, Japan, Lithuania, Malta, Mexico, Netherlands, New Zealand, Poland, Romania, Singapore, Tunisia, Turkey, United Kingdom, United States, South Africa

Active ingredients

The drug RETROVIR contains one active pharmaceutical ingredient (API):

1 Zidovudine UNII 4B9XT59T7S - ZIDOVUDINE

Zidovudine is an antiviral agent which is highly active in vitro against retroviruses including the Human Immunodeficiency Virus (HIV). Read about Zidovudine

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
RETROVIR Concentrate for solution for infusion	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC
RETROVIR Oral solution/syrup	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC
RETROVIR Capsules, hard	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J05AF01	Zidovudine	J Antiinfectives for systemic use → J05 Antivirals for systemic use → J05A Direct acting antivirals → J05AF Nucleoside and nucleotide reverse transcriptase inhibitors
Discover more medicines within J05AF01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 10266H, 10360G, 10361H
Country: CA	Health Products and Food Branch	Identifier(s): 01902644, 01902652, 01902660
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 26.014-10-04
Country: EE	Ravimiamet	Identifier(s): 1113422, 1664670
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 57486
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 115591
Country: FR	Base de données publique des médicaments	Identifier(s): 60132743, 60524598, 63894243, 69290545
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 379090, 43938, 43941, 43944, 46203
Country: HK	Department of Health Drug Office	Identifier(s): 42757, 59602
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 3108, 3543, 4298, 8648
Country: JP	医薬品医療機器総合機構	Identifier(s): 6250001M1038
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1090662, 1090663
Country: MT	Medicines Authority	Identifier(s): MA1297/00101, PI565/07804A
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 142M91, 248M91
Country: NL	Z-Index G-Standaard	Identifier(s): 13619519, 14009919
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 24724, 33499, 36943
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 5021, 5022, 5023
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100081337, 100081343, 100198097, 100198499
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W65176002, W65176003, W65176004, W65177001, W65177002
Country: SG	Health Sciences Authority	Identifier(s): 07527P
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 23013011H
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699522152285, 8699522572687, 8699522772605
Country: US	FDA, National Drug Code	Identifier(s): 49702-211, 49702-212, 49702-213
Country: ZA	Health Products Regulatory Authority	Identifier(s): 29/20.2.8/0483